Search all trials

Find therapies in clinical trials near you – page 114

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 968
countries: 28
conditions: 2 103

3 968 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Crohn's disease

Not recruiting

Investigational

Study on the Long-Term Safety and Effectiveness of Upadacitinib for Patients with Moderate to Severe Crohn's Disease

Investigational

France

Participants:18–64 years · 65+ years
Substances:Upadacitinib

Contact Research Centre

Acute lymphocytic leukaemia recurrent

Not recruiting

Registered drugNo placebo

Study of Inotuzumab Ozogamicin Alone and with Drug Combination for Children with Relapsed or Refractory Acute Lymphoblastic Leukemia

Registered drugNo placebo

France

Participants:0–17 years
Substances:Inotuzumab Ozogamicin

Contact Research Centre

Kidney transplant rejection

Not recruiting

Registered drugNo placebo

Study on Tegoprubart for Preventing Kidney Transplant Rejection in Patients

Registered drugNo placebo

France

Participants:18–64 years
Substances:At-1501

Contact Research Centre

Systemic lupus erythematosus

Not recruiting

Investigational

Study on the Effects of Upadacitinib in Adults with Moderate to Severe Systemic Lupus Erythematosus (SLE)

Investigational

France

Participants:18–64 years
Substances:Upadacitinib

Contact Research Centre

Deep vein thrombosis+1

Not recruiting

Registered drug

Study on the Effectiveness and Safety of BAY 3018250 and Low Molecular Weight Heparin for Patients with Proximal Deep Vein Thrombosis

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Bay 3018250

Contact Research Centre

Crohn's disease

Not recruiting

Registered drugNo placebo

Study on Managing Moderate Postoperative Recurrence in Crohn's Disease with Infliximab for Patients After Ileocolonic Surgery

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Infliximab

Contact Research Centre

Hormone receptor positive HER2 negative breast cancer

Not recruiting

Registered drug

Study of Pembrolizumab with Chemotherapy for High-Risk Early-Stage ER+/HER2- Breast Cancer Patients

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Doxorubicin

Contact Research Centre

Dementia of the Alzheimer's type uncomplicated

Not recruiting

Investigational

Study of XPro1595 for Patients with Early Alzheimer's Disease and Inflammation Markers

Investigational

France

Participants:18–64 years · 65+ years
Substances:Pegipanermin

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study Comparing Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Patients with Untreated Multiple Myeloma Not Planning Stem Cell Transplant

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Bortezomib

Contact Research Centre

Portal hypertension

Not recruiting

Investigational

Study on the Effects of BI 685509 for Patients with Liver Cirrhosis and Portal Hypertension After First Decompensation Event

Investigational

France

Participants:18–64 years · 65+ years
Substances:Bi 685509

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study Comparing Zimberelimab and Domvanalimab with Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Domvanalimab

Contact Research Centre

Diffuse large B-cell lymphoma+2

Not recruiting

Registered drugNo placebo

Study of Glofitamab and Obinutuzumab for Patients with Relapsed or Refractory Lymphomas After CAR T-cell Therapy

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Glofitamab

Contact Research Centre

Find therapies in clinical trials near you – page 114

1 504 trials match your criteria

Crohn's disease

Study on the Long-Term Safety and Effectiveness of Upadacitinib for Patients with Moderate to Severe Crohn's Disease

Acute lymphocytic leukaemia recurrent

Study of Inotuzumab Ozogamicin Alone and with Drug Combination for Children with Relapsed or Refractory Acute Lymphoblastic Leukemia

Kidney transplant rejection

Study on Tegoprubart for Preventing Kidney Transplant Rejection in Patients

Systemic lupus erythematosus

Study on the Effects of Upadacitinib in Adults with Moderate to Severe Systemic Lupus Erythematosus (SLE)

Deep vein thrombosis+1

Study on the Effectiveness and Safety of BAY 3018250 and Low Molecular Weight Heparin for Patients with Proximal Deep Vein Thrombosis

Crohn's disease

Study on Managing Moderate Postoperative Recurrence in Crohn's Disease with Infliximab for Patients After Ileocolonic Surgery

Hormone receptor positive HER2 negative breast cancer

Study of Pembrolizumab with Chemotherapy for High-Risk Early-Stage ER+/HER2- Breast Cancer Patients

Dementia of the Alzheimer's type uncomplicated

Study of XPro1595 for Patients with Early Alzheimer's Disease and Inflammation Markers

Plasma cell myeloma

Study Comparing Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Patients with Untreated Multiple Myeloma Not Planning Stem Cell Transplant

Portal hypertension

Study on the Effects of BI 685509 for Patients with Liver Cirrhosis and Portal Hypertension After First Decompensation Event

Non-small cell lung cancer

Study Comparing Zimberelimab and Domvanalimab with Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer

Diffuse large B-cell lymphoma+2

Study of Glofitamab and Obinutuzumab for Patients with Relapsed or Refractory Lymphomas After CAR T-cell Therapy

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.